Claudia Schweizer

Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors

Jian‐Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey et al. · Journal for ImmunoTherapy of Cancer · 2021 · 58 citations · Full text

Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy

Claudia Schweizer, Philipp Schubert, Sandra Rutzner et al. · European Journal of Cancer · 2020 · 34 citations

Cancer Immunosurveillance, Medicine, Melanoma +9

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

Luisa Maria Griewing, Claudia Schweizer, Philipp Schubert et al. · BMC Cancer · 2021 · 18 citations · Full text

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors

Philipp Schubert, Sandra Rutzner, Markus Eckstein et al. · Frontiers in Oncology · 2020 · 14 citations · Full text